Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last ¥5,870 JPY
Change Today 0.00 / 0.00%
Volume 76.1K
3593 On Other Exchanges
Symbol
Exchange
Tokyo
OTC US
As of 2:00 AM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

hogy medical co ltd (3593) Snapshot

Open
¥5,880
Previous Close
¥5,870
Day High
¥5,900
Day Low
¥5,810
52 Week High
01/30/15 - ¥6,240
52 Week Low
04/25/14 - ¥5,200
Market Cap
95.9B
Average Volume 10 Days
82.5K
EPS TTM
¥359.82
Shares Outstanding
16.3M
EX-Date
06/26/15
P/E TM
16.3x
Dividend
¥116.00
Dividend Yield
1.91%
Current Stock Chart for HOGY MEDICAL CO LTD (3593)

Related News

No related news articles were found.

hogy medical co ltd (3593) Related Businessweek News

No Related Businessweek News Found

hogy medical co ltd (3593) Details

Hogy Medical Co., Ltd. develops and supplies various medical products for healthcare facilities in Japan and internationally. It offers orthopedic surgery, cesarean, and angio kit products, which are the sets of surgical supplies for use in operating theater procedures; and non-woven products comprising gowns, caps, underwear, drapes, packaged products, equipment covers, kurumu, towels, masks, and accessories for use in operating rooms, outpatient areas, hospital wards, and other areas, as well as provides Tigalyer, a multi-layer fabric material. The company also offers sterilization products, such as Mekkin bags that are sterilized storage packages pouch product; Mekkin cards, which are detection cards used to judge the sterilization process when sterilizing in an autoclave; ethylene oxide gas cards that are detection cards used to judge the sterilization process when sterilizing using ethylene oxide gas; indicator tapes for autoclave sterilization; and Mukinlock sterile storage lockers, which provide storage for sterilized medical materials and instruments. In addition, it provides IC Tracer, a gauze control system that uses integrated circuit chips embedded in each gauze used during surgery, making each one traceable; ASRC, which is made of a foamed polyethylene sponge that provides flexibility and functionality for use in varying procedures and inosculations of pancreaticoduodenectomy; SECUREA, a sponge for endoscopic surgery; and Opera Master, which is a surgery management system for collecting various information related to the surgery rooms. The company was formerly known as Hogy Co., Ltd. and changed its name to Hogy Medical Co., Ltd. in 1987. Hogy Medical Co., Ltd. was founded in 1955 and is headquartered in Tokyo, Japan.

Founded in 1955

hogy medical co ltd (3593) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

hogy medical co ltd (3593) Key Developments

Hogy Medical Co. Ltd. expected to report Fiscal Year 2015 results on April 24, 2015. This event was calculated by Capital IQ (Created on April 18, 2015).

Hogy Medical Co. Ltd. expected to report Fiscal Year 2015 results on April 24, 2015. This event was calculated by Capital IQ (Created on April 18, 2015).

Hogy Medical Co. Ltd. Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2015; Provides Consolidated and Non-Consolidated Earnings Guidance for the First Six Months of Fiscal Year 2016 and Year Ending March 31, 2016

Hogy Medical Co. Ltd. reported consolidated and non-consolidated earnings results for the year ended March 31, 2015. For the year, on consolidated basis, the company reported net sales of JPY 35,233 million against JPY 34,793 million a year ago. Operating income was JPY 8,505 million against JPY 8,747 million a year ago. Ordinary income was JPY 8,768 million against JPY 9,055 million a year ago. Net income was JPY 5,659 million or JPY 359.81 per share compared to JPY 5,632 million or JPY 358.10 per share for the same period a year ago. Income before income taxes and minority interests was JPY 8,678 million compared to JPY 8,885 million a year ago. Net cash provided by operating activities was JPY 7,935 million compared to JPY 9,349 million a year ago. Purchase of tangible fixed assets was JPY 10,525 million compared to JPY 1,625 million a year ago. Purchase of intangible fixed assets was JPY 1,266 million compared to JPY 588 million a year ago. For the year, on non-consolidated basis, the company reported total net sales of JPY 34,985 million against JPY 34,605 million a year ago. Operating income was JPY 7,651 million against JPY 7,966 million a year ago. Ordinary income was JPY 8,030 million against JPY 8,371 million a year ago. Net income was JPY 5,142 million or JPY 326.95 per share compared to JPY 5,160 million or JPY 328.05 per share for the same period a year ago. Income before income taxes and minority interests was JPY 7,939 million compared to JPY 8,200 million a year ago. The company provided consolidated and non-consolidated earnings guidance for the first six months of fiscal year 2016 and year ending March 31, 2016. For the six months, on consolidated basis, expects net sales of JPY 18,170 million, operating income of JPY 4,340 million, ordinary income of JPY 4,410 million and net income of JPY 2,910 million or JPY 185.01 per share. For the year, on consolidated basis expects net sales of JPY 37,100 million, operating income of JPY 8,290 million, ordinary income of JPY 8,420 million and net income of JPY 5,500 million or JPY 349.68 per share. For the six months, on non-consolidated basis, expects net sales of JPY 18,010 million, operating income of JPY 3,889 million, ordinary income of JPY 3,959 million and net income of JPY 2,574 million or JPY 163.65 per share. For the year, on non-consolidated basis expects net sales of JPY 36,780 million, operating income of JPY 7,533 million, ordinary income of JPY 7,743 million and net income of JPY 5,016 million or JPY 318.91 per share.

Hogy Medical Co. Ltd. Presents at Mizuho New York Healthcare Conference 2015, Mar-02-2015

Hogy Medical Co. Ltd. Presents at Mizuho New York Healthcare Conference 2015, Mar-02-2015 . Venue: Omni Berkshire Place, 21 East 52nd Street at Madison Ave, New York, NY 10022, United States. Speakers: Jun-Ichi Hoki, Chief Executive Officer, President, Director and Chairman of Internal Control Committee.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
3593:JP ¥5,870.00 JPY 0.00

3593 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cardinal Health Inc $91.38 USD -0.12
Halyard Health Inc $49.27 USD +0.09
Paul Hartmann AG €374.00 EUR +8.00
View Industry Companies
 

Industry Analysis

3593

Industry Average

Valuation 3593 Industry Range
Price/Earnings 16.4x
Price/Sales 2.6x
Price/Book 1.1x
Price/Cash Flow 17.0x
TEV/Sales 1.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HOGY MEDICAL CO LTD, please visit www.hogy.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.